...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: A vs V
1
Mar 27, 2019 01:04PM
6
Mar 29, 2019 01:05PM
2
Mar 29, 2019 02:01PM
4
Mar 29, 2019 07:25PM
2
Mar 29, 2019 07:59PM
4
bfw
Mar 29, 2019 09:04PM

The "problem" here is that no one knows how Vascepa works. So no one would know whether or not they'd be complementary until a specific Phase 3 were to be run, right?

Anyway, it seems to me that A is more a threat to V than the other way around. If that's the case, the owners of AMRN stock should be concerned....

 

 

2
Mar 29, 2019 09:27PM
Share
New Message
Please login to post a reply